Safety of Onabotulinum- Toxin-A for Chronic Migrainein patients with Psoriasis of the scalp and Sturge WeberSyndrome: A case series and Literature Review

Abstract

Chronic Migraine (CM) is defined as >15 headache episodes per month [1]. It approximately affects 2% of the population worldwide [2]. Risk of migraine is increased among patients with Psoriasis [3,4]. Sturge Weber Syndrome is also reported to be related to chronic migraine headaches, but poorly documented [5,6]. Onabotulinum Toxin-A (Botulinum Toxin-A) has shown to be effective for prophylaxis of headache in patients with chronic migraine [7]. Albeit, the effects of Botox used for Chronic Migraine in patients with skin lesions are not well studied. We report the use of Onabotulinum Toxin-A for Chronic Migraine in patients with (i.e., Scalp Psoriasis and Sturge-Weber Syndrome).